Intercept Pharmaceuticals, Inc.

JACOBS LEVY EQUITY MANAGEMENT, INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

861,801

Value ($000)

9,532

Weight

0.1%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	9,532	0.1%	861,801	6/30/2023
2023 Q1	5/15/2023	12,401	0.1%	923,369	3/31/2023
2022 Q4	2/14/2023	11,419	0.1%	923,107	12/31/2022
2022 Q3	11/15/2022	10,894	0.1%	780,945	9/30/2022
2022 Q2	8/15/2022	8,917	0.1%	645,691	6/30/2022
2022 Q1	5/16/2022	9,637	0.1%	592,304	3/31/2022
2021 Q4	2/14/2022	9,594	0.1%	588,922	12/31/2021
2021 Q3	11/15/2021	7,933	0.1%	534,176	9/30/2021
2021 Q2	8/16/2021	12,259	0.1%	613,888	6/30/2021
2021 Q1	5/17/2021	12,281	0.1%	532,102	3/31/2021
2020 Q4	2/16/2021	11,849	0.1%	479,724	12/31/2020
2020 Q3	11/16/2020	14,397	0.1%	347,246	9/30/2020
2020 Q2	8/17/2020	2,369	0.0%	49,457	6/30/2020
2020 Q1	5/15/2020	2,770	0.0%	44,002	3/31/2020
2019 Q4	2/14/2020	5,495	0.1%	44,342	12/31/2019